J&J, Schering OTC Advertising Outpaced DTC Spending In 2003
This article was originally published in The Tan Sheet
Johnson & Johnson spent approximately 40% more on OTC drug advertising in the first nine months of 2003 than on direct-to-consumer prescription drug advertising
You may also be interested in...
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands